Literature DB >> 3517042

Isolation of highly encapsulated Cryptococcus neoformans serotype B from a patient in New York City.

E J Bottone, P A Kirschner, I F Salkin.   

Abstract

For the first time, Cryptococcus neoformans serotype B was isolated from a patient in New York City, not a region endemic for B/C serotypes. The isolate was morphologically unusual, with cells several times larger in infected tissue than those characteristic of the yeastlike pathogen. This anomaly may be a problem in the identification of similar isolates. Two serotype differentiation media and a slide agglutination test were used for definitive serotype identification.

Entities:  

Mesh：

Year:  1986        PMID： 3517042      PMCID： PMC268599          DOI： 10.1128/jcm.23.1.186-188.1986

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  8 in total

1.  The antigenic composition of Cryptococcus neoformans. I. A serologic classification by means of the capsular and agglutination reactions.

Authors:  E E EVANS
Journal:  J Immunol       Date:  1950-05       Impact factor: 5.422

2.  Cryptococcus neoformans of unusual morphology.

Authors:  J G Cruickshank; R Cavill; M Jelbert
Journal:  Appl Microbiol       Date:  1973-02

3.  Large Cryptococcus neoformans isolated from brain abscess.

Authors:  G L Love; G D Boyd; D L Greer
Journal:  J Clin Microbiol       Date:  1985-12       Impact factor: 5.948

4.  New medium for differentiation of Cryptococcus neoformans serotype pairs.

Authors:  I F Salkin; N J Hurd
Journal:  J Clin Microbiol       Date:  1982-01       Impact factor: 5.948

5.  Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C).

Authors:  K J Kwon-Chung; I Polacheck; J E Bennett
Journal:  J Clin Microbiol       Date:  1982-03       Impact factor: 5.948

6.  Epidemiologic differences among serotypes of Cryptococcus neoformans.

Authors:  J E Bennett; K J Kwon-Chung; D H Howard
Journal:  Am J Epidemiol       Date:  1977-06       Impact factor: 4.897

7.  Caffeic acid-containing medium for identification of Cryptococcus neoformans.

Authors:  R L Hopfer; F Blank
Journal:  J Clin Microbiol       Date:  1976-08       Impact factor: 5.948

8.  Serotype B/C Cryptococcus neoformans isolated from patients in nonendemic areas.

Authors:  R A Fromtling; S Shadomy; H J Shadomy; W E Dismukes
Journal:  J Clin Microbiol       Date:  1982-08       Impact factor: 5.948
  8 in total
  8 in total

1.  Emergence of Cryptococcus gattii in a novel environment provides clues to its incubation period.

Authors:  L MacDougall; M Fyfe
Journal:  J Clin Microbiol       Date:  2006-05       Impact factor: 5.948

2.  First case of human cryptococcosis due to Cryptococcus neoformans var. gattii in Spain.

Authors:  M Francisca Colom; Susana Frasés; Consuelo Ferrer; Alejandro Jover; Mariano Andreu; Sergio Reus; Manuel Sánchez; Josep M Torres-Rodríguez
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

3.  Prevalence of Cryptococcus neoformans var. neoformans (Serotype D) and Cryptococcus neoformans var. grubii (Serotype A) isolates in New York City.

Authors:  J N Steenbergen; A Casadevall
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

4.  Evaluation of a monoclonal antibody-based latex agglutination test for diagnosis of cryptococcosis: comparison with two tests using polyclonal antibodies.

Authors:  A Temstet; P Roux; J L Poirot; O Ronin; F Dromer
Journal:  J Clin Microbiol       Date:  1992-10       Impact factor: 5.948

5.  Cryptococcus neoformans varieties as agents of cryptococcosis in Brazil.

Authors:  R Rozenbaum; A J Gonçalves; B Wanke; M J Caiuby; H Clemente; M dos S Lazera; P C Monteiro; A T Londero
Journal:  Mycopathologia       Date:  1992-09       Impact factor: 2.574

Review 6.  Current trends in the prevalence of Cryptococcus gattii in the United States and Canada.

Authors:  Ana Espinel-Ingroff; Sarah E Kidd
Journal:  Infect Drug Resist       Date:  2015-05-11       Impact factor: 4.003

7.  Cryptococcus gattii in the United States: genotypic diversity of human and veterinary isolates.

Authors:  Shawn R Lockhart; Naureen Iqbal; Julie R Harris; Nina T Grossman; Emilio DeBess; Ron Wohrle; Nicola Marsden-Haug; Duc J Vugia
Journal:  PLoS One       Date:  2013-09-03       Impact factor: 3.240

8.  The granuloma in cryptococcal disease.

Authors:  Laura C Ristow; J Muse Davis
Journal:  PLoS Pathog       Date:  2021-03-18       Impact factor: 6.823
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.